Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

por Reichmann, Heinz, Lees, Andrew, Rocha, José-Francisco, Magalhães, Diogo, Soares-da-Silva, Patrício
Publicado 2020

Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

por Reichmann, Heinz, Lees, Andrew, Rocha, José-Francisco, Magalhães, Diogo, Soares-da-Silva, Patrício
Publicado 2020

Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged ≥ 65 Years with Focal Seizures

por Costa, Raquel, Steinhoff, Bernhard, Gama, Helena, Ikedo, Fábio, Rocha, José-Francisco, Soares-da-Silva, Patrício
Publicado 2018

Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10‐2474: A Double‐Blind, Randomized, Placebo‐Controlled Study in Healthy Volunteers

por Rocha, José‐Francisco, Santos, Ana, Gama, Helena, Moser, Paul, Falcão, Amílcar, Pressman, Peter, Wallace Hayes, A., Soares‐da‐Silva, Patricio
Publicado 2021

Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Control...

por Ferreira, Joaquim J., Poewe, Werner, Rascol, Olivier, Stocchi, Fabrizio, Antonini, Angelo, Moreira, Joana, Pereira, Ana, Rocha, José-Francisco, Soares-da-Silva, Patrício
Publicado 2022

Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease

por Ferreira, Joaquim J., Poewe, Werner, Rascol, Olivier, Stocchi, Fabrizio, Antonini, Angelo, Moreira, Joana, Guimarães, Bruno, Rocha, José‐Francisco, Soares‐da‐Silva, Patrício
Publicado 2022

The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II

por Rocha, José-Francisco, Ebersbach, Georg, Lees, Andrew, Tolosa, Eduardo, Ferreira, Joaquim J., Poewe, Werner, Rascol, Olivier, Stocchi, Fabrizio, Antonini, Angelo, Magalhães, Diogo, Gama, Helena, Soares-da-Silva, Patrício
Publicado 2021

The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II

por Rocha, José-Francisco, Ebersbach, Georg, Lees, Andrew, Tolosa, Eduardo, Ferreira, Joaquim J., Poewe, Werner, Rascol, Olivier, Stocchi, Fabrizio, Antonini, Angelo, Magalhães, Diogo, Gama, Helena, Soares-da-Silva, Patrício
Publicado 2022

Pooled efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: Data from four double‐blind placebo‐controlled pivotal phase III cl...

por Elger, Christian, Koepp, Mathias, Trinka, Eugen, Villanueva, Vicente, Chaves, João, Ben‐Menachen, Elinor, Kowacs, Pedro A., Gil‐Nagel, António, Moreira, Joana, Gama, Helena, Rocha, José‐Francisco, Soares‐da‐Silva, Patrício
Publicado 2017

Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind O...

por Chaudhuri, K. Ray, Odin, Per, Ferreira, Joaquim J., Antonini, Angelo, Rascol, Olivier, Kurtis, Mónica M., Storch, Alexander, Bannister, Kirsty, Soares-da-Silva, Patrício, Costa, Raquel, Magalhães, Diogo, Rocha, José Francisco
Publicado 2022